The National Cancer Institute IRCCS Fondazione Pascale will host the special lecture “Gender Oncology”, part of the Multidisciplinary Workshops & Special Lectures 2026 series.

The event will feature Rossana Berardi, President-Elect of the Italian Medical Oncology Association (AIOM), and will be hosted by Alfredo Budillon.

The meeting will take place at the Istituto Nazionale Tumori G. Pascale – Aula R. Cerra.

The international course “From Imaging Biomarkers to Clinical Translation: Inclusion and Equity in Molecular Imaging and AI” will take place on 25 September 2026 at the IRCCS San Raffaele Hospital in Milan.

The event will bring together leading national and international experts to discuss some of the most innovative and pressing topics in Nuclear Medicine and Molecular Imaging. The programme will cover a wide range of subjects, including imaging biomarkers, theranostics, regulatory aspects of radiopharmaceuticals, quantitative imaging, and the latest applications of artificial intelligence.

The course aims to foster multidisciplinary discussion on the role of molecular imaging and artificial intelligence in translational research and clinical practice, with particular emphasis on the development and validation of novel imaging biomarkers, quantitative imaging approaches, and theranostic applications. Special attention will be given to the themes of inclusion, equity, and responsible innovation, which are essential to ensuring the effective and sustainable integration of emerging technologies into precision medicine.

The workshop “Young Investigators Day on Liquid Biopsy and Translational Biomarkers: Inclusive Approaches in Precision Oncology” will take place on 6 October 2026 at the Centro Formazione Bastianelli, IRCCS Istituto Nazionale dei Tumori Regina Elena in Rome. The event is organized in partnership with the Società Italiana di Biopsia Liquida (SIBIL) and several institutions affiliated with A_IATRIS.

Designed as a highly interactive Young Investigators Day, the workshop is primarily aimed at PhD students, medical residents, postdoctoral fellows and early-career clinician scientists. The programme will explore the latest advances in liquid biopsy and translational biomarkers, covering topics such as circulating tumor DNA, circulating tumor cells, extracellular vesicles, multi-omics approaches and artificial intelligence applications in precision oncology. The event will combine keynote lectures, presentations by young investigators and networking opportunities to foster scientific exchange and collaboration.

The workshop will conclude with the presentation of Young Investigator Awards, recognizing outstanding contributions from early-career researchers.

The event programme is available here.

The workshop “Integrating Sex and Gender Perspectives in Translational Oncology and Precision Medicine” will take place on 21 October 2026 at the Istituto Nazionale Tumori – IRCCS Fondazione G. Pascale in Naples.

The event is organized by the Istituto Nazionale Tumori – IRCCS Fondazione G. Pascale in Naples, in collaboration with the IRCCS Istituto di Ricerche Farmacologiche Mario Negri and the IRCCS Istituto Ortopedico Rizzoli.

The workshop will explore the integration of sex and gender perspectives throughout the translational oncology research continuum, from preclinical studies to clinical applications. Particular attention will be given to precision medicine, biomarker discovery, and the contribution of omics and multi-omics technologies to understanding biological variability and developing personalised therapeutic strategies.

Beyond the scientific dimension, the event will also address institutional strategies to advance gender equality in research, including the implementation of Gender Equality Plans, in line with European research and innovation priorities.

For more information, please visit the event webpage.

The whorkshop “Inclusion and Equity in MSC Translational Medicine: A Next-Generation Interactive Workshop” will take place on 27–28 October 2026 at IRCCS Ospedale Galeazzi–Sant'Ambrogio, Milan.

The event, organized under the umbrella of the GISM Next-Generation section of the Italian Mesenchymal Stem Cell Society (GISM), will promote an equity-by-design approach in MSC translational medicine, bringing together researchers, clinicians, social scientists, patient representatives and stakeholders to discuss how translational research can become more inclusive, representative and equitable. Through keynote lectures, roundtables and collaborative discussions, participants will address biological and sex-related biases in MSC research, representativeness in translational and clinical studies, equitable access to ATMPs, AI and data equity, precision medicine, and ethical, social and regulatory aspects of translational medicine. Particular emphasis will be placed on the involvement of young researchers and on fostering multidisciplinary collaborations with national and European organizations, including EATRIS-related experts and infrastructures, APRE, and organizations working on diversity, inclusion and gender equity.

Two Young Researcher Awards will be awarded to selected authors of submitted abstracts. Abstract Submission Deadline: 4 October 2026

Attendance is free of charge, but registration is mandatory.

For more information, please visit the event webpage.

The event programme is available here.

The event “Precision medicine innovations for diagnosis and therapy of tissue and organ failures: From the research infrastructures to the healthcare” will take place on 6 November 2026 at the IRCCS ISMETT, Palermo.

This workshop will provide an interdisciplinary forum to explore cutting-edge advances in precision and regenerative medicine, with a particular focus on innovative approaches to the diagnosis and treatment of tissue and organ dysfunction. Jointly organized by IRCCS ISMETT and IRCCS Ospedale Galeazzi–Sant’Ambrogio, the workshop aims to foster scientific collaboration, strengthen translational research networks, and promote the integration of technological innovation, research infrastructures, and patient perspectives to accelerate the development of more effective, personalized diagnostic and therapeutic strategies.

Hybrid event: in-person and online participation.

Participation is open and free to everyone, but the registration is required. Register here to participate.

For more details, please see the programme.

Further information about the event is available in the official press release

The workshop “Inclusive Imaging Futures: AI, Tracers and Equity in Precision Medicine” will take place on 9 November 2026 at the Università Cattolica del Sacro Cuore – Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome, with the option to participate either in person or online

Organised by Università Cattolica del Sacro Cuore and Fondazione Policlinico Universitario A. Gemelli IRCCS, in collaboration with Ospedale San Raffaele IRCCS, the event will explore inclusive imaging ecosystems, patient and community involvement, and the translation of AI and imaging innovation into policy and practice.

The programme will address topics such as theranostics, digital twins, AI-driven cancer imaging, federated infrastructures, and the pathway from translational research to policy uptake and real-world implementation. Bringing together experts from research, healthcare and innovation, the workshop will foster discussion on how emerging imaging technologies and artificial intelligence can support more equitable and accessible precision medicine.

For more details, please consult the programme.

Registration is now open.

The workshop “Digital Transformation in Health as an Inclusive Practice” will take place on 17 November 2026 at the Istituto di Ricerche Farmacologiche Mario Negri IRCCS in Milan, with the option to participate either in person or online.

The event is organized by the Istituto di Ricerche Farmacologiche Mario Negri IRCCS in collaboration with the Istituto Nazionale Tumori IRCCS Fondazione G. Pascale.

The workshop will explore digital transformation in health from an inclusive perspective, focusing on the needs of underrepresented populations and how different stakeholders can work together to foster a more inclusive approach. The programme will combine stakeholder perspectives, an interactive board game and a roundtable discussion.

For more details, please see the preliminary programme.

Registration is open until 2 November 2026. Register here to participate.

The event “Governing Biomedical Innovation for the Public Good,” organised by the National Cancer Institute Fondazione IRCCS and the Mario Negri Institute for Pharmacological Research in Milan, explores how biomedical research and innovation can better meet the needs of diverse populations, reduce health inequalities, and ensure that no patient is left behind.

This event explores how biomedical research and innovation can translate scientific discoveries into meaningful public benefits, ensuring that advances in healthcare are accessible, equitable, and inclusive. The morning session will address key challenges, including equitable access to innovative treatments and the need to ensure a fair public return on publicly funded research. The afternoon session will focus on technology transfer and biomedical innovation, exploring how research institutions can translate scientific discoveries into real-world applications while fostering responsible, inclusive, and socially impactful innovation.

The event will bring together researchers, clinicians, research funders, experts in innovation transfer and alternative innovation incentives, and civil society groups to discuss the key challenges in governing biomedical innovation

Registration is open until 16 Novembr 2026. Register here to participate.

For more details, please see the programme.

For further information, please contact +39 02 2390 2301 or email direzione.scientifica@istitutotumori.mi.it